Detalhe da pesquisa
1.
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Clin Cancer Res
; 9(10 Pt 1): 3578-88, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14506144